Kura Oncology

KURA ONCOLOGY INC

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Kura Oncology Inc

Kura Sushi USA, Inc. - Class A Common Stock

Kura Sushi USA Inc

Kura Sushi Inc

Kuraray Co Ltd

Earnings

Press Releases

Kura Oncology Reports Second Quarter 2025 Financial Results

News

Kura Oncology to Participate in Three Upcoming Investor Conferences

Health Care

General

Kura Oncology to Host Virtual Investor and Analyst Events on Farnesyl Transferase Inhibitor Program

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology Highlights Preclinical Data Demonstrating Potential of Farnesyl Transferase Inhibitors to Overcome Drug Resistance in Combination with Key Targeted Therapies Across Multiple Tumor Types

Kura Oncology to Participate in Upcoming Investor Conference

Small Cap

Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology

Kura Oncology and Kyowa Kirin Announce First Patient Dosed in Pivotal Phase 3 KOMET-017 Trial of Ziftomenib for Frontline Acute Myeloid Leukemia (AML)

Kura Oncology and Kyowa Kirin Launch Clinical Trial Evaluating Dual Inhibition of NPM1 and FLT3 Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

KURA

Arbutus Biopharma Corporation - Common Stock

Arbutus Biopharma

Akebia Therapeutics

AnaptysBio

ArriVent BioPharma

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

BridgeBio Oncology Therapeutics, Inc. - Common Stock

BridgeBio Oncology

Bicara Therapeutics

CareDx

Day One Biopharmaceuticals, Inc. - Common Stock

Day One Biopharmaceutical

Geron

Iovance Biotherapeutics, Inc. - Common Stock

Iovance Biotherapeutics

Inventiva S.A. - American Depository Shares

Inventiva

Kodiak Sciences

Nurix Therapeutics

Oruka Therapeutics

Pharming Group N.V. - ADS, each representing 10 ordinary shares

Pharming

Palvella Therapeutics, Inc. - Common Stock

Palvella Therapeutics

Rezolute

Spyre Therapeutics

Tango Therapeutics

UroGen Pharma

Valneva

Vir Biotechnology

Xencor

Zenas BioPharma

HC Wainwright & Co.

JMP Securities

Wedbush

Mizuho

Comments

Kura Oncology

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO